SCHEMBL8973501

SCHEMBL8973501

CCCOC(=O)c1sccc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 4/20 0.46
TSHR P16473 2/20 0.45
ESR1 P03372 1/20 0.45
CHRM1 P11229 1/20 0.45
SLC6A2 P23975 1/20 0.45
KDR P35968 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 2/20 0.43
PKM P14618 1/20 0.42
GRM6 O15303 1/20 0.42
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
PDE4D Q08499 1/20 0.41
POLB P06746 2/20 0.41
STS P08842 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL930157 0.86 ALDH1A1 (0.50) ALDH1A1MAPTLMNAHSD17B10PKM
Hydrochloric Acid SCHEMBL8801734 0.85 ALDH1A1 (0.49) ALDH1A1MAPTLMNAHSD17B10PKM
SCHEMBL10941833 0.80 ALDH1A1 (0.47) ALDH1A1MAPTLMNATSHRESR1
SCHEMBL8973493 0.78 STS (0.47) ALDH1A1MAPTLMNATSHRESR1
SCHEMBL17147852 0.78 ALDH1A1 (0.58) ALDH1A1MAPTLMNATSHRESR1
SCHEMBL27516574 0.78 ALDH1A1 (0.53) ALDH1A1MAPTLMNATSHRESR1
SCHEMBL16173995 0.78 ALDH1A1 (0.49) ALDH1A1MAPTLMNATSHRESR1
Hydrochloric Acid SCHEMBL9148624 0.77 STS (0.46) ALDH1A1MAPTLMNATSHRESR1
SCHEMBL102285 0.77 KMT2A (0.54) ALDH1A1MAPTLMNAHSD17B10PKM
SCHEMBL4786272 0.75 ALDH1A1 (0.54) ALDH1A1MAPTLMNATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10556890-B2 Heteroaryl compounds and methods of use thereof SUNOVION PHARMACEUTICALS INC. (US) 2020-02-11 US disclosed
US-20180118727-A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2018-05-03 US disclosed
US-5508441-A Herbicidal substituted thienylsulphonylureas BAYER AKTIENGESELLSCHAFT (DE) 1996-04-16 US disclosed
US-5430006-A Herbicidal substituted thienylsulphonylureas BAYER AKTIENGESELLSCHAFT (DE) 1995-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10556890-B2 Heteroaryl compounds and methods of use thereof COMT, GRIN2C, TPMT ALDH1A1 1165/4885MAPT 185/4885LMNA 3780/4885
US-20180118727-A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF COMT, GRIN2C, TPMT ALDH1A1 1165/4885MAPT 185/4885LMNA 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.